ClinicalTrials.gg
Enrolling by invitationNCT06124222Updated Dec 5, 2024

Prosthetic Rehabilitation and Its Influence on Masticatory Performance and QoL in Patients Treated for HNC

An interventional study of Prosthetic oral rehabilitation in Quality of Life, Objective Masticatory Performance and Subjective Masticatory Performance, sponsored by University of Barcelona. Enrolling by invitation at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-05.

Sponsored by University of Barcelona · Not applicable, Interventional, and Screening

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as enrolling by invitation.
  • Registered 1 year 11 months after the study started (first participant enrolled Nov 2021, registered Nov 2023).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 128 studies in Head and Neck Neoplasms with a site in Spain — 16 open to participants now, 35 under way, 7 of them phase 3. Head and Neck Neoplasms · Spain.

Planned enrollment
115th of 123
21 · median 141
Started
2021
with 12 others
No phase
12 of 128
3 open now
Primary completion
2025-11
later than 10 of 34 live
Registered
117th of 128
by date

Among the 128 studies in Head and Neck Neoplasms with a site in Spain, this one is the 115th largest by planned enrollment of the 123 interventional ones that give a count, is one of 13 that started in 2021, is one of 12 with no phase, reaches primary completion later than 10 of the 34 other live ones, and was the 117th registered.

Head and Neck Neoplasms

2,718 studies on the registry are indexed under Head and Neck Neoplasms; 599 are open to participants now.

Browse Head and Neck Neoplasms studies →

Open to participants now

16 of the 128 studies in Head and Neck Neoplasms with a site in Spain are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 458 Head and Neck Neoplasms studies recruiting now, 350 (76%) set no upper age limit and 51 (11%) stop at 75 or younger; 22 take children under 18; 27 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 128 studies in Head and Neck Neoplasms with a site in Spain, or all of them as a file.
02

Study summary

The main goal of this clinical trial (pilot study) is to evaluate whether prosthetic rehabilitation modifies objective masticatory performance, subjective masticatory performance, quality of life, salivary flow and pH in patients treated for head and neck cancer before and after the placement of fixed and/or removable prostheses.

Hypothesis Prosthetic rehabilitation with fixed and/or removable prostheses modifies objective masticatory performance, subjective masticatory performance, quality of life, salivary flow and pH in non-irradiated patients treated for head and neck cancer compared to irradiated patients.

Study population The study population will consist of patients treated for head and neck cancer who are candidates for prosthetic rehabilitation. The type of prosthetic treatment recommended will be determined by a dental expert in the treatment of these patients.

Interventions

    • First session and recruitment:

      • Oral health status.
      • Sialometry and salivary pH.
      • Subjective masticatory performance.
      • Objective masticatory performance.
      • Quality of life.
    • Prosthodontic treatment.
    • Second session (after insertion of the prosthesis)

      After an adaptation period of ± 15-30 days from the insertion of the prosthesis, the recordings carried out in the first session will be performed again:

      • Oral health status.
      • Sialometry and salivary pH.
      • Subjective masticatory performance.
      • Objective masticatory performance.
      • Quality of life.
    • Third session (follow-up 6 months)

After a period of time of 3 months ± 7 days after the second session, the recordings carried out in the first and second sessions will be performed again:

  • Oral health status.
  • Sialometry and salivary pH.
  • Subjective masticatory performance.
  • Objective masticatory performance.
  • Quality of life.
Read the detailed description

The adverse effects of oncological treatment can alter both the functional and esthetic capabilities of patients, resulting in a diminished quality of life. Dental rehabilitation with prostheses is used to restore the loss of these parameters. Therefore, it is important to know whether patients treated for head and neck cancer improve their masticatory performance, and therefore their quality of life, when rehabilitated with fixed or removable prostheses.

Masticatory function is altered after oncologic treatment in patients with head and neck cancer, causing a decrease in their quality of life. Therefore, there is a need to know whether patients treated for head and neck cancer improve their masticatory performance and masticatory function, and therefore their quality of life, when rehabilitated with fixed or removable prostheses, as well as to know whether this variation in parameters is maintained over time. In addition, it is important to evaluate other aspects that are also directly related to quality of life and masticatory function, such as oral health, the level of salivary secretion and its pH.

03

Conditions studied

  • Quality of Life
  • Objective Masticatory Performance
  • Subjective Masticatory Performance
  • Oral Health

Keywords

  • Masticatory Performance
  • Quality of Life
  • Head Neck Cancer
  • Oral Rehabilitation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects over 18 years of age who accept the conditions of the study.
  • Patients diagnosed and treated for head and neck cancer in the stable phase of their oncologic pathology.
  • Patients in need of prosthetic rehabilitation treatment and who agree to be treated.

Exclusion criteria

Exclusion Criteria:

  • Subjects under 18 years of age and/or who do not accept the conditions of the study.
  • Diagnosis of cancer in regions other than those mentioned in the inclusion criteria.
  • Present a tumor recurrence at the time of the study, undefined oncologic evolutionary situation or under oncologic treatment.
  • Presence of orofacial pain or craniomandibular dysfunction hindering mandibular movement and or participation in the study.
  • Present a disability to complete the different records.
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
21 participants (estimated)

Study arms

  • Active comparator
    Group A

    Patients who have not received RT in their oncologic treatment (non-irradiated).

    Procedure: Prosthetic oral rehabilitation

  • Experimental
    Group B

    Patients who have received RT in their oncologic treatment (irradiated).

    Procedure: Prosthetic oral rehabilitation

Interventions

  • ProcedureProsthetic oral rehabilitation

    Prosthetic rehabilitation with fixed and/or removable prosthesis.

06

What researchers measure

Primary outcomes

  1. Objective Masticatory Performance

    The chewing test consists of chewing a latex bag with 2g of silicone during 20 chewing cycles counted by the same subject. It will be repeated 5 times. Until 10 grams of Opto-Zeta silicone have been chewed, the masticatory performance will be calculated by median particle size (MPS).

    Time frame: 6 months

  2. Quality of life

    It will be analyzed on the basis of the adapted OHIP-14Sp (Oral Health Impact Profile) questionnaire, which will be given to the patients and completed by them. It consists of 14 questions, grouped in pairs and distributed in the following seven categories: functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability and handicap.

    Time frame: 6 months

  3. Subjective masticatory performance

    It will be analyzed on the basis of the adapted QMF (Quality of Masticatory Function) questionnaire, which will be given to the patients and completed by them. It consists of 29 questions related to the frequency and ease of chewing different types of food. The questions are classified into five groups: eating and chewing skills, habits, meats, fruits and vegetables.

    Time frame: 6 months

  4. Sialometry and salivary pH

    ▪ Unstimulated salivary secretion: the patient will be seated with the head forward, facilitating the accumulation of saliva on the floor of the mouth. The saliva will be deposited in short intervals in a glass for 5 minutes. The collected content is then measured in a graduated tube. ▪ Stimulated salivary secretion: in the same position as the previous test, the patient will chew a portion of paraffin wax for 5 minutes. Saliva is collected in the glass at short intervals during the chewing period. Afterwards, the content will be measured in a graduated tube. ▪ pH: in one of the vessels with accumulated saliva from the previous tests, the salivary pH will be measured by means of paper strips, whose color will be compared with a visual scale. The color obtained on the strip will be compared with the color scale, which establishes a color for each pH value (1 to 14).

    Time frame: 6 months

07

Study locations

1 site
  • Carlos Moreno Soriano
    L'Hospitalet de Llobregat, Barcelona 08901, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2021 (actual). Primary completion is estimated for Nov 2025, 48 months after the start.

Of 440 non-industry interventional studies with no phase under Head and Neck Neoplasms, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 71. This study's planned 48 months is above that.

Counting every sponsor, half of 458 studies reached it within 33 months; a quarter within 18 and three quarters within 70.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2023
First posted
Nov 9, 2023
StartActual
Nov 17, 2021
Primary completionEst.
Nov 2025
CompletionEst.
Dec 2025
Last update
Dec 5, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06124222
Responsible party
Carlos Moreno Soriano (MSc, University of Barcelona) — Principal investigator
First posted
Nov 9, 2023
Start date
Nov 17, 2021
Primary completion
Nov 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Dec 5, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion